Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 7

Session: PrEP

Long-acting Injectable PrEP for HIV Prevention: Where we are and where we're going

Friday, October 1, 2021
2:45 PM - 4:00 PM EDT
Participants should be aware of the following financial/non-financial relationships:
Raphael J. Landovitz, MD, MSc: Gilead Sciences (Individual(s) Involved: Self): Consultant; Janssen (Individual(s) Involved: Self): Consultant; Merck Inc (Individual(s) Involved: Self): Consultant; Roche (Individual(s) Involved: Self): Consultant

    Speaker(s)

  • Raphael J. Landovitz, MD, MSc

    Professor of Medicine
    UCLA Center for Clinical AIDS Research & Education
    Los Angeles, CA, United States

    Gilead Sciences (Individual(s) Involved: Self): Consultant; Janssen (Individual(s) Involved: Self): Consultant; Merck Inc (Individual(s) Involved: Self): Consultant; Roche (Individual(s) Involved: Self): Consultant